These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3632148)

  • 1. Reversible adsorption (desorption) of aspirin from activated charcoal.
    Filippone GA; Fish SS; Lacouture PG; Scavone JM; Lovejoy FH
    Arch Intern Med; 1987 Aug; 147(8):1390-2. PubMed ID: 3632148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of ipecac and activated charcoal/cathartic. Prevention of salicylate absorption in a simulated overdose.
    Curtis RA; Barone J; Giacona N
    Arch Intern Med; 1984 Jan; 144(1):48-52. PubMed ID: 6140906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of kaolin-pectin and activated charcoal for inhibition of aspirin absorption.
    Juhl RP
    Am J Hosp Pharm; 1979 Aug; 36(8):1097-8. PubMed ID: 484570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of activated charcoal and magnesium citrate in the prevention of aspirin absorption in humans.
    Easom JM; Caraccio TR; Lovejoy FH
    Clin Pharm; 1982; 1(2):154-6. PubMed ID: 7185512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed salicylate toxicity at 35 hours without early manifestations following a single salicylate ingestion.
    Rivera W; Kleinschmidt KC; Velez LI; Shepherd G; Keyes DC
    Ann Pharmacother; 2004; 38(7-8):1186-8. PubMed ID: 15173556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the adsorption capacities of an activated-charcoal--yogurt mixture versus activated-charcoal--water slurry in vivo and in vitro.
    Hoegberg LC; Christophersen AB; Christensen HR; Angelo HR
    Clin Toxicol (Phila); 2005; 43(4):269-75. PubMed ID: 16035203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activated charcoal alone and followed by whole-bowel irrigation in preventing the absorption of sustained-release drugs.
    Lapatto-Reiniluoto O; Kivistö KT; Neuvonen PJ
    Clin Pharmacol Ther; 2001 Sep; 70(3):255-60. PubMed ID: 11557913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition by ice cream of the antidotal efficacy of activated charcoal.
    Levy G; Soda DM; Lampman TA
    Am J Hosp Pharm; 1975 Mar; 32(3):289-91. PubMed ID: 1136978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-volume whole bowel irrigation and salicylate absorption: a comparison with ipecac-charcoal.
    Olsen KM; Ma FH; Ackerman BH; Stull RE
    Pharmacotherapy; 1993; 13(3):229-32. PubMed ID: 8100628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of five activated charcoal formulations for inhibition of aspirin absorption and palatability in man.
    Scholtz EC; Jaffe JM; Colaizzi JL
    Am J Hosp Pharm; 1978 Nov; 35(11):1355-9. PubMed ID: 707504
    [No Abstract]   [Full Text] [Related]  

  • 11. The bioavailability of two beta-blockers preadsorbed onto charcoal.
    Roivas L; Ojala-Karlsson P; Neuvonen PJ
    Methods Find Exp Clin Pharmacol; 1994 Mar; 16(2):125-32. PubMed ID: 7911863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enteral exsorption of acetaminophen after intravenous injection in rats: influence of activated charcoal on this clearance path.
    Eyer F; Jung N; Neuberger H; Schulz R; Steiner K; Ladstetter B; Poethko T; Henke J; Zilker T
    Basic Clin Pharmacol Toxicol; 2007 Sep; 101(3):163-71. PubMed ID: 17697035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saline catharsis: effect on aspirin bioavailability in combination with activated charcoal.
    Sketris IS; Mowry JB; Czajka PA; Anderson WH; Stafford DT
    J Clin Pharmacol; 1982 Jan; 22(1):59-64. PubMed ID: 7061727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of activated charcoal on the bioavailability of piroxicam in man.
    Laufen H; Leitold M
    Int J Clin Pharmacol Ther Toxicol; 1986 Jan; 24(1):48-52. PubMed ID: 3957490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The adsorption of salicylates by a milk chocolate-charcoal mixture.
    Eisen TF; Grbcich PA; Lacouture PG; Shannon MW; Woolf A
    Ann Emerg Med; 1991 Feb; 20(2):143-6. PubMed ID: 1996795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of activated charcoal administration on acetylcysteine serum levels in humans.
    North DS; Peterson RG; Krenzelok EP
    Am J Hosp Pharm; 1981 Jul; 38(7):1022-4. PubMed ID: 7258201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seromucosal transport of intravenously administered carbamazepine is not enhanced by oral doses of activated charcoal in rats.
    Eyer F; Jung N; Neuberger H; Witte A; Poethko T; Henke J; Zilker T
    Basic Clin Pharmacol Toxicol; 2008 Mar; 102(3):337-46. PubMed ID: 18248517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Successful therapy of salicylate poisoning using glycine and activated charcoal].
    Mühlebach S; Steger P; Conen D; Wyss PA
    Schweiz Med Wochenschr; 1996 Dec; 126(49):2127-9. PubMed ID: 8999500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desorption of furosemide from charcoal in vitro and in man.
    Roivas L; Kivistö KT; Neuvonen PJ
    Int J Clin Pharmacol Ther; 1994 Jul; 32(7):365-9. PubMed ID: 7952799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of activated charcoal on the pharmacokinetics and the clinical features of carbamazepine poisoning.
    Brahmi N; Kouraichi N; Thabet H; Amamou M
    Am J Emerg Med; 2006 Jul; 24(4):440-3. PubMed ID: 16787802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.